Phase 2 Non-Small Cell Lung Cancer Metastatic trials recruiting now

All Non-Small Cell Lung Cancer Metastatic trials, every phase

Phase 2 Non-Small Cell Lung Cancer Metastatic trials

• A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
  NCT07292168 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
  NCT06741085 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
  NCT05657873 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib
  NCT06378892 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
  NCT06517953 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
  NCT06106802 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• PALACE: Cemiplimab Trial According to ctDNA Levels
  NCT06917573 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer
  NCT07250477 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.